Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Neratinib Targets Vascular Inflammation in Atherosclerosis Models
January 2026
Neratinib markedly reduced vascular inflammation and atherosclerosis in mice by targeting ASK1, boosting effects with rosuvastatin.
Read more
14 Dec 2025
SABCS 2025: Tracking GLP-1 Use in Breast Cancer Care
Real-world study shows GLP-1 use in breast cancer linked to clinical factors, social determinants, and ctDNA.
13 Dec 2025
SABCS 2025: Early MRI Predicts Immunotherapy Response
Early MRI predicts pathologic complete response and long-term outcomes in TNBC patients receiving pembrolizumab.
12 Dec 2025
SABCS 2025: Biomarker Changes After Neoadjuvant Therapy
SABCS 2025 data show frequent biomarker changes in inflammatory breast cancer after neoadjuvant therapy.
12 Dec 2025
SABCS 2025: Gaps Persist in Metastatic HR+ Breast Cancer Care
New SABCS data reveal racial and socioeconomic disparities in metastatic HR+ breast cancer presentation and treatment timing.
12 Dec 2025
Exercises Shape Swallowing Outcomes In Head And Neck Cancer
For patients with head and neck cancer receiving radiation therapy, dysphagia can emerge early and persist as a chronic or late complication.
10 Dec 2025
Biosynthetic Mesh Breast Reconstruction Shows Promise
Pilot data suggest biosynthetic mesh breast reconstruction may offer acceptable outcomes for high-risk implant candidates.
7 Dec 2025
PARP Inhibitors Extend Control in Ovarian Cancer
PARP inhibitor maintenance therapy improved progression free survival in newly diagnosed advanced ovarian cancer but not survival.
5 Dec 2025
Robotic Minimally Invasive Esophagectomy After Neoadjuvant Therapy
Propensity matched data suggest robotic minimally invasive esophagectomy offers shorter hospital stay after neoadjuvant therapy compared with open approaches.
Loading posts...
« Previous
1
2
3
4
5
…
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View